Correlation Between SAB Biotherapeutics and Connect Biopharma

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Connect Biopharma Holdings, you can compare the effects of market volatilities on SAB Biotherapeutics and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Connect Biopharma.

Diversification Opportunities for SAB Biotherapeutics and Connect Biopharma

-0.44

Correlation Coefficient

SAB Biotherapeutics  Connect Biopharma

Very good diversification

The 3 months correlation between SAB and Connect is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Connect Biopharma go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Connect Biopharma

Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 2.19 times more return on investment than Connect Biopharma. However, SAB Biotherapeutics is 2.19 times more volatile than Connect Biopharma Holdings. It trades about 0.12 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about 0.16 per unit of risk. If you would invest  319.00  in SAB Biotherapeutics on September 12, 2024 and sell it today you would earn a total of  66.00  from holding SAB Biotherapeutics or generate 20.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

SAB Biotherapeutics  vs.  Connect Biopharma Holdings

SAB Biotherapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, SAB Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Connect Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Connect Biopharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with SAB Biotherapeutics and Connect Biopharma

The main advantage of trading using opposite SAB Biotherapeutics and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.

The idea behind SAB Biotherapeutics and Connect Biopharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.